Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer

SIMPLE SUMMARY: Using a first-principles approach, we demonstrate how standard-of-care therapies for bone metastatic prostate cancer (BMPCa) patients can be optimized with the use of routine measurements to significantly delay the evolution of resistant disease, potentially extending overall patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Araujo, Arturo, Cook, Leah M., Frieling, Jeremy S., Tan, Winston, Copland, John A., Kohli, Manish, Gupta, Shilpa, Dhillon, Jasreman, Pow-Sang, Julio, Lynch, Conor C., Basanta, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915310/
https://www.ncbi.nlm.nih.gov/pubmed/33567529
http://dx.doi.org/10.3390/cancers13040677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915310/
https://www.ncbi.nlm.nih.gov/pubmed/33567529
http://dx.doi.org/10.3390/cancers13040677

Ejemplares similares